Ustekinumab-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn's Disease

Ustekinumab is a common biologic therapy for the treatment of inflammatory bowel disease. Posterior reversible encephalopathy syndrome (PRES) is an uncommon condition consisting of a constellation of neurologic findings and characteristic findings on imaging. The association between ustekinumab and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, Ariel, Kinnucan, Jami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534360/
https://www.ncbi.nlm.nih.gov/pubmed/36212237
http://dx.doi.org/10.14309/crj.0000000000000867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534360/
https://www.ncbi.nlm.nih.gov/pubmed/36212237
http://dx.doi.org/10.14309/crj.0000000000000867

Ejemplares similares